clx

Clorox (NYSE: CLX), a consumer-products business that counts Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL) as related stocks, may have seen a sales drop of 1% in its fiscal first quarter, but that didn't stop it from posting a nice bottom-line growth rate. Clorox made $1.11 per share in Q1, and that represents a 23% increase. What a way to start a new corporate year!

According to Reuters, expectations were for 95 cents per share. That's a wonderful beat. Plus, sales volume went up 1%. Helping to drive things along was a healthy gross margin, as well as the dreaded H1N1 virus. Clorox has done well over the years associating its brand with sanitizing effectiveness, so when a pandemic rears its ugly head, the trademark is prepared to leverage such reputation to drive value.

Many investors need income, especially as they reach retirement. They look for ancillary cash flow to supplement their Social Security payments and any retirement benefits from a company for which they've worked. But those aren't the only investors who should be interested in income.

That's because studies show that dividends are a significant contributor to overall performance of a stock. When held for years, a stock's dividend can help diminish the volatility of a stock's price and keep returns reasonable, especially in down markets. Here are five stocks that have decent income as well as potential capital gains. All are exceptionally financially strong.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Alcoa Inc. (NYSE: AA) reported a surprise Q3 profit due to cost cutting; revenue topped estimates as well.
• Avis Budget Group Inc. (NYSE: CAR) said a proposed offering of $250 million in notes could reduce earnings.
• Clorox Co. (NYSE: CLX) earnings prospects garnered it an upgrade from one analyst.
• Coca-Cola Co. (NYSE: KO) earnings prospects resulted in an upgrade from one analyst.
• Costco Wholesale Corp. (NASDAQ: COST) lower Q4 earnings topped analysts' expectations, lifting shares.
• Family Dollar Stores Inc. (NYSE: FDO) higher Q4 earnings beat analysts' estimates but sales were just OK.

Analyst upgrades:

• Deutsche Bank upgraded Clorox (NYSE: CLX) to Buy from Hold on valuation and believes upside to earnings forecasts is likely. The firm raised its target on shares to $66 from $65.
• Kaufman Bros. upgraded eBay (NASDAQ: EBAY) to Buy from Hold on expectations improved Marketplace fundamentals will serve as a positive catalyst for shares. The firm raised its price target on the stock to $29 from $22.
• Roth Capital believes Zumiez (NASDAQ: ZUMZ) is well positioned for improved results and margins. The firm, which upgraded shares to Buy from Hold and raised its target to $22 from $16, said September back-to-school results bode well for the holiday season and demonstrate that Zumiez can drive conversion during peak shopping periods.
• Northrop Grumman (NYSE: NOC) was upgraded to Sell from Conviction Sell at Goldman.
• Adobe (NASDAQ: ADBE) was upgraded to Outperform from Neutral at Baird.
• Monster Worldwide (NYSE: MWW) was upgraded to Overweight from Neutral at JPMorgan.

Analyst upgrades:

• FBR Capital upgraded Ann Taylor (NYSE: ANN) to Outperform from Market Perform to reflect a recovery in the missy sector and the company's product improvement. The firm raised its target on shares to $19 from $13.
• Roth Capital upgraded Marvell Tech (NASDAQ: MRVL) to Buy from Hold based on product cycle strength in wireless and Ethernet, HDD share gains, and a return of PC growth. Target is $22.
• Goldman upgraded Colgate (NYSE: CL) to Buy from Neutral citing valuation and expectations for a pick-up in unit growth. The firm raised its price target to $85 from $83. Note that Goldman downgraded Clorox to Neutral from Buy.
• Cadbury (NYSE: CBY) was upgraded to Neutral from Underweight at HSBC.
• Garmin (NASDAQ: GRMN) was upgraded to Buy from Underperform at BofA/Merrill.
• Qwest (NYSE: Q) was upgraded to Market Weight from Underweight at Thomas Weisel.

So you're not exactly enamored with this market? The green shoots don't look that strong to you, and with U.S. unemployment approaching 10%, that's hardly fodder for an 'everyone in to the pool' dive into stocks.

As a financial publishing colleague frequently says, "I hear ya on that one." With the above in mind, why not consider a defensive play or two? Here are three plays that will enable you to sleep well at night, and also position you for some upside.

Here are some highlights from last week's earnings coverage from BloggingStocks:

• Activision Blizzard Inc. (NASDAQ: ATVI) reported better-than-expected Q2 results, sending shares higher.
• Blackstone Group (NYSE: BX) said it swung to a Q2 profit despite a dearth of leveraged buyouts.
• CBS Corp. (NYSE: CBS) Q2 earnings declined but still topped estimates, sending shares higher.
• Coinstar Inc. (NASDAQ: CSTR) reported stellar Q2 results driven by its the popularity of RedBox.
• Clorox Co. (NYSE: CLX) posted solid Q4 earnings but said revenues were flat due to currency effects.
• Duke Energy Corp. (NYSE: DUK) lower Q2 earnings beat expectations by a penny but revenue fell short.

U.S. stock markets may be poised to rise, extending their gains from earlier this week, as traders bet that the worst of the steepest economic decline since the Great Depression is ending. Then again, they may end their recent winning streak.

It's one of those days.

S&P Futures expiring in September were little changed as investors digested the latest batch of earnings news. These recent quarterly reports have been largely viewed positively. Some investors may be worrying if stock valuations have gotten too rich.

The Clorox Company (NYSE: CLX), a famous supermarket brand similar to companies such as Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL), reported Q4 earnings today. Excluding certain factors, Clorox increased its per-share profit by 18% to $1.35.

The dollar continues to wreak havoc on companies with international exposure (there's a whole lot of them, of course). Including currency translations, Clorox's top line was flat. Without the effect (and excluding the impact of a private-label business that the company exited), sales increased 3%. The company utilized price increases to help offset the tough times. Unfortunately, volume decreased 2% during the quarter.

Colgate-Palmolive (NYSE: CL), whose colleagues at the supermarket include companies like Procter & Gamble (NYSE: PG) and Clorox (NYSE: CLX), did all right in the second quarter. Sales were inhibited by currency rates: they dropped by well over 5%. The bottom line, on the other hand, fared a lot better. The company made $1.07 per share compared to 92 cents per share in the year-ago period. However, the previous year's quarter had 6 cents of charges to take into account, so the adjusted earnings in 2008 actually comes out to 98 cents. This makes the growth rate a modest 9%. The market was expecting $1.05 per share according to Earnings.com, so management beat by two pennies.

I was surprised a little by how the stock sold off on Thursday after the earnings report. Shares of Colgate-Palmolive closed down over 5% on very active volume.

First recommended on November 16, 2007, Clorox was one of those well-established, demonstrated business model giants that was rudely treated by Wall Street, with the Street taking shares down to about $45 from $62.

Institutional investors punished Clorox (NYSE: CLX) for its erratic performance, but the view from here argues that stance was too harsh. Clorox's businesses are solid, but were affected by both the housing downturn (fewer households) and seasonal factors.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• American Capital Agency Corp. (NASDAQ: AGNC) earnings prospects earned it an analyst's upgrade.
• Broadpoint Securities Group Inc. (NASDAQ: BPSG) earnings prospects improved with recent acquisitions.
• Clorox Co. (NYSE: CLX) was upgraded on the belief that its fiscal year outlook is too conservative.
• Deutsche Bank (NYSE: DB) earnings prospects resulted in an upgrade from JPMorgan.
• Lululemon Athletica Inc. (NASDAQ: LULU) Q1 profit and same-store sales fell and it offered a weak outlook.
• Movado Group Inc. (NYSE: MOV) bested Q1 expectations and forecast a considerable profit for the full year.

The Clorox Company (NYSE: CLX), a company whose compatriots at the supermarket include Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL), gave and received some good news this week. First, let's mention the giving. Management saw fit to increase the dividend that it pays to shareholders. The quarterly payout went up 9% to $0.50 per share.

Now, for the receiving. According to an earlier item on BloggingStocks, Oppenheimer thinks the stock is worthy of an outperform rating. A price target of $70 has been set. Which is impressive, since the price of Clorox as of this writing is $56.32 per share.

TheStreet.com's Jim Cramer suggests watching certain staples for hints that the flight to riskier plays is losing steam.

Will the endless "beta" trade out of slow-moving, "safe" drugs and foods and into companies like Freeport-McMoRan (NYSE: FCX) (Cramer's Take) and Caterpillar (NYSE: CAT) (Cramer's Take) ever end?

I think it won't end here, that's for certain, unless your staples stock goes to a 5% yield and the economy's macro data show a further breakdown. If we get some retail sales that are awful and some employment numbers that show a further trashing, then we are going to see a momentary blip up in stocks like Pepsi (NYSE: PEP) (Cramer's Take) and Clorox (NYSE: CLX) (Cramer's Take), but perhaps no more than that.

WD-40 (NASDAQ: WDFC), whose consumer-product colleagues include Procter & Gamble (NYSE: PG) and Clorox (NYSE: CLX), issued its second-quarter report on Wednesday after the market closed. The numbers were a bit rusty (yes, the bad pun was on purpose!).

First, we have a big net-sales drop of over 20%. Then, we have a 50% decline in net income, with earnings coming in at 25 cents per share. And finally, we see that the 25-cent per-share number missed estimates by two pennies according to this source. Management blamed the bad results in part on the weak global economy and on currency translations.